Article Link: FDA Approves Onureg (azacitidine tablets) as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemia ...
FDA Approves Xaracoll (bupivacaine hydrochloride) Implant for Acute Postsurgical Pain Relief Following Open Inguinal Hernia Repair
Article Link: FDA Approves Xaracoll (bupivacaine hydrochloride) Implant for Acute Postsurgical Pain Relief Following Open Inguinal Hernia Repair ...
FDA Approves Sogroya (somapacitan-beco) a Once-Weekly Treatment for Adult Growth Hormone Deficiency
Article Link: FDA Approves Sogroya (somapacitan-beco) a Once-Weekly Treatment for Adult Growth Hormone Deficiency Plainsboro, NJ, Aug 28,...
FDA Approves Winlevi (clascoterone) Cream for the Treatment of Acne
Article Link: FDA Approves Winlevi (clascoterone) Cream for the Treatment of Acne Lainate, Italy – August 27, 2020 – Cassiopea SpA (SIX: ...
FDA Approves Cystadrops (cysteamine) Ophthalmic Solution for the Ocular Manifestations of Cystinosis
Article Link: FDA Approves Cystadrops (cysteamine) Ophthalmic Solution for the Ocular Manifestations of Cystinosis LEBANON, N.J., Aug. 25...
FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis
Article Link: FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis Basel, August 20,...
FDA Approves New Kyprolis (carfilzomib) Combination Regimen with Darzalex (daratumumab) and Dexamethasone in Both Once- And Twice-Weekly Dosing Regimens
Article Link: FDA Approves New Kyprolis (carfilzomib) Combination Regimen with Darzalex (daratumumab) and Dexamethasone in Both Once- And Twice-Weekly...
FDA Approves Enspryng (satralizumab-mwge) for Neuromyelitis Optica Spectrum Disorder
Article Link: FDA Approves Enspryng (satralizumab-mwge) for Neuromyelitis Optica Spectrum Disorder South San Francisco, CA — August...
FDA Approves Viltepso (viltolarsen) for the Treatment of Duchenne Muscular Dystrophy in Patients Amenable to Exon 53 Skipping Therapy
Article Link: FDA Approves Viltepso (viltolarsen) for the Treatment of Duchenne Muscular Dystrophy in Patients Amenable to Exon 53 Skipping Therapy�...
FDA Approves Olinvyk (oliceridine) Injection for the Management of Severe Acute Pain
Article Link: FDA Approves Olinvyk (oliceridine) Injection for the Management of Severe Acute Pain CHESTERBROOK, Pa., Aug. 10, 2020 (GLOB...
